Panacea Biotec, Apotex settle dispute over breach of collaboration agreementPanacea Biotec settles arbitration disputes with Apotex Inc., with Panacea Biotec Pharma Ltd. set to receive a net USD 2 million. The settl...
09 Jul, 2025, 08.10 PM IST
Cipla gets USFDA nod for generic cancer drugCipla has secured USFDA approval to market a generic version of Abraxane, paclitaxel protein-bound particles for injectable suspension (100...
11 Apr, 2025, 11.59 AM IST
Cipla shares zoom nearly 10% as USFDA classifies Goa facility for voluntary actionCipla's shares surged 9.8% after the USFDA classified its Goa facility inspection as Voluntary Action Indicated (VAI), allowing for critica...
31 Oct, 2024, 10.04 AM IST
Venus Remedies gets marketing authorisations for three cancer drugs from UkraineSaransh Chaudhary, President, Global Critical Care, Venus Remedies, said, "These marketing approvals mark a significant milestone in our gl...
18 Mar, 2024, 12.38 PM IST
Venus Remedies gets marketing authorisation from Philippines, Saudi Arabia for three oncology drugsPharma major Venus Remedies on Wednesday said it has received marketing authorisation from Philippines and Saudi Arabia for three oncology ...
06 Dec, 2023, 12.36 PM IST
Venus Remedies gets marketing approval for six chemotherapy drugs from PhilippinesVenus Remedies has already submitted dossiers to the Health Ministry of the Philippines for additional 45 marketing authorisations, and mos...
16 Oct, 2023, 12.15 PM IST
Alembic Pharma gets USFDA nod for generic injection to treat cancerThe approval granted by the US Food & Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) for Paclitaxel injecti...
27 Oct, 2022, 12.23 PM IST
Essential medicine for leukemia, stomach cancer to become cheaper in IndiaThe regulatory body has cut by nearly 30% the price of Imatinib, used to treat cancers and blood diseases, including different types of leu...
07 Jun, 2016, 12.51 PM IST
Technology varsity in Madhya Pradesh 'discovers' anti-cancer moleculesBhopal-based RGPV announced that it has applied for a US patent of the discovery of the new anti-cancer molecules code named "CTR-17 and CT...
07 Dec, 2015, 03.56 PM IST
Indian study on treating diabetics with heart ailments gets global recognitionAs per the findings, the use of Everolimus eluting stents may be equally or more useful in treating coronary blockages in diabetic patients...
25 Oct, 2015, 12.39 PM IST
Government caps price of 18 formulation packsAs per the notification, the prices of formulations including Diclofenac Sodium, Clotrimazole, Mesalamine, Omeprazole+Domperidone and Vanco...
26 Aug, 2015, 10.17 PM IST
Sun Pharma gets DGCI nod for breast cancer drugSun Pharma Advanced Research Company today said it has received the approval of the DGCI for its medicine for treatment of breast cancer.
23 Jan, 2014, 10.57 PM IST
- Panacea to launch breast cancer drug; stock down
Panacea Biotec is planning to introduce its indigenously developed Albumin bound paclitaxel particles formulation called PacliAll.
10 Feb, 2011, 02.59 PM IST
- Dabur Pharma net up; in talks for acquisitions
Dabur Pharma’s net profit has increased to Rs 2.7 crore for the quarter ended March 31, 2007 from Rs 20.6 lakh in the corresponding period ...
18 May, 2007, 01.25 AM IST
- Dabur Pharma Q4 net up 13 fold
Spurred by better product mix and controlled expenses in manufacturing, Dabur Pharma's net profit in the fourth quarter ended March 31 grew...
17 May, 2007, 07.50 PM IST
- Dabur Pharma sets arm in US to tap oncology mkt
Dabur Pharma on Wednesday said it has set up a subsidiary company in the US, which will be directly responsible for sales, marketing and di...
09 May, 2007, 02.20 PM IST
- Dabur Pharma launches new chemotherapy treatment
Dabur Pharma on Thursday launched its new nano technology based chemotherapy agent, Nanoxel, in the country.
04 Jan, 2007, 01.40 PM IST